![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Athawale R, Acharya N, Samal S, Hariharan C. 2013. Effect of mifepristone in cervical ripening for induction of labour. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2:35–38.
- Baev OR, Rumyantseva VP, Tysyachnyu OV, Kozlova OA, Sukhikh GT. 2017. Outcomes of mifepristone usage for cervical ripening and induction of labour in full term pregnancy. Randomized controlled trial. European Journal of Obstetrics & Gynecology and Reproductive Biology 217:144–149.
- Berkane N, Verstraete L, Uzan S, Boog G, Maria B. 2005. Use of mifepristone to ripen the cervix and induce labor in term pregnancies. American Journal of Obstetrics and Gynecology 192:114–120.
- Elliott CL, Brennand JE, Calder AA. 1998. The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics and Gynecology 92:804–809.
- Gallot D, De Lapasse C, Houlle C, Sapin V, Laurichesse-Dalmas H, Saulnier JP, et al. 2004. Obstetrical prognosis of labour induction with mifepristone after 41 weeks of gestation. Gynecologie Obstetrique & Fertilite 32:708–712.
- Hapangama D, Neilson JP. 2009. Mifepristone for induction of labour. Cochrane Database Systematic Review (3):CD002865. doi: 10.1002/14651858.CD002865.pub2.
- Heikinheimo O. 1997. Clinical Pharmacokinetics of Mifepristone. Clinical Pharmacokinetics 33:7.
- Wing DA, Fassett MJ, Mishell DR. 2000. Mifepristone for preinduction cervical ripening beyond 41 weeks' gestation: a randomized controlled trial. Obstetrics and Gynecology 96:543–548.
- Yelikar K, Deshpande S, Deshpande R, Lone D. 2015. Safety and efficacy of oral mifepristone in pre-induction cervical ripening and induction of labour in prolonged pregnancy. The Journal of Obstetrics and Gynecology of India 65:221–225.